SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
Figueiredo, J.C., Ihenacho, U., Merin, N.M., Hamid, O., Darrah, J., Gong, J., Paquette, R., Mita, A.C., Vescio, R., Mehmi, I., Basho, R., Salvy, S.J., Shirazipour, C.H., Caceres, N., Finster, L.J., Coleman, B., Arnow, H.U., Florindez, L., Sobhani, K., Prostko, J.C., Frias, E.C., Stewart, J.L., Merchant, A., Reckamp, K.L.
Published in Annals of oncology (01.01.2022)
Published in Annals of oncology (01.01.2022)
Get full text
Journal Article
Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)
McArthur, H.L., Basho, R., Shiao, S., Park, D., Dang, C., Karlan, S., Knott, S., Mita, M., Dilauro Abaya, C., Giuliano, A.E., Dadmanesh, F., Ho, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1871 Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC)
Basho, R, Janku, F, Helgason, T, Gilcrease, M, Booser, D, Karp, D, Meric-Bernstam, F, Wheler, J, Valero, V, Albarracin, C, Litton, J, Chavez-MacGregor, M, Ibrahim, N, Murray, J, Koenig, K, Hong, D, Subbiah, V, Kurzrock, R, Moulder, S
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
A Phase 1 Study of TAK-676, a Novel STING Agonist, Plus Pembrolizumab Following Radiation Therapy in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC), Triple-Negative Breast Cancer (TNBC), or Squamous-Cell Carcinoma of the Head and Neck (SCCHN)
Gerber, N.K., Chmura, S.J., Luke, J.J., Shiao, S.L., Basho, R., Iams, W.T., Page, D.B., Li, C., Gregory, R.C., Shaw, M.H., Horn, K.H., Gibbs, J., Appleman, V.A., Berger, A., Abu-Yousif, A.O., Lineberry, N.B., Stumpo, K.F., Elfiky, A., Cooper, B.
Published in International journal of radiation oncology, biology, physics (01.11.2022)
Published in International journal of radiation oncology, biology, physics (01.11.2022)
Get full text
Journal Article
1611P Health-related quality of life, vaccine uptake and immune response among cancer patients undergoing treatment during the COVID-19 pandemic
Figueiredo, J.C., Merin, N., Ihenacho, U., Hamid, O., Hendifar, A.E., Vescio, R., Paquette, R., Natale, R.B., Darrah, J., Basho, R., McArthur, H., Nguyen, N., Punwani, N., Herrera, E., Cheng, S., Salvy, S-J., Datta, G., Figlin, R., Merchant, A., Reckamp, K.L.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Impact of Age in Women with Stage I-III Triple Negative Breast Cancer (TNBC): A National Cancer Data Base (2004-2014) Report
Schiff, J., Sittig, M.P., Cook-Wiens, G., Mirhadi, A.J., Burnison, M., Amersi, F., Chung, A., Dang, C., Giuliano, A.E., Karlan, S., Basho, R., el-Masry, M., McAndrew, P., McArthur, H.L., Mita, M., Park, D., Shiao, S.L.
Published in International journal of radiation oncology, biology, physics (01.11.2020)
Published in International journal of radiation oncology, biology, physics (01.11.2020)
Get full text
Journal Article
Abstract OT3-04-02: Neoadjuvant Her2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial
McArthur, HL, Leal, JHS, DiLauro Abaya, C, Basho, R, Coleman, H, Shiao, S, Knott, S, Tighiouart, M, Dadmanesh, F, Giuliano, A, Verma, S
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
271TiPPreoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)
McArthur, H L, Basho, R, Shiao, S, Park, D, Dang, C, Karlan, S, Knott, S, Mita, M, Dilauro Abaya, C, Giuliano, A E, Dadmanesh, F, Ho, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
287TiPNeoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial
McArthur, H L, Leal, J H S, Page, D B, Bardia, A, Spring, L, Abaya, C D, Basho, R K, Ristow, L, Coleman, H, Shiao, S, Knott, S, Tighiouart, M, Dadmanesh, F, Verma, S, Giuliano, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Abstract P2-09-07: Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)
McArthur, HL, Basho, R, Shiao, SL, Park, D, Mita, M, Chung, A, Arnold, B, Martin, C, Dang, C, Karlan, S, Knott, S, Giuliano, A, Ho, A
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P2-09-03: Updated efficacy of first or second-line pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) and correlations with baseline lymphocyte and naïve CD4+ T-cell count
Page, DB, Pucilowska, J, Bennetts, L, Kim, I, Sanchez, K, Martel, M, Conlin, A, Moxon, N, Mellinger, S, Acheson, A, Kemmer, K, Mitri, Z, Vuky, J, Ahn, J, Abaya, C, Manigault, T, Basho, R, Urba, WJ, McArthur, HL
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P3-14-02: Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer (TNBC): Evidence of efficacy and proof of concept from a phase I trial with dose expansion of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab
Basho, RK, Gilcrease, M, Murthy, RK, Helgason, T, Booser, DJ, Karp, DD, Meric-Bernstam, F, Wheler, JJ, Valero, V, Albarracin, C, Litton, J, Chavez-MacGregor, M, Ibrahim, NK, Murray, JL, Koenig, KB, Hong, D, Subbiah, V, Kurzrock, R, Janku, F, Moulder, S
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article